Darlow B A, Horwood L J, Clemett R S
Department of Paediatrics, Christchurch School of Medicine, Christchurch Hospital, New Zealand.
Paediatr Perinat Epidemiol. 1992 Jan;6(1):62-80. doi: 10.1111/j.1365-3016.1992.tb00747.x.
A prospective study of risk factors for retinopathy of prematurity (ROP) in all very low birthweight (less than 1500 g) infants born in New Zealand in 1986 is reported. Of 413 liveborn infants admitted to neonatal units, 338 (81.2%) survived to be discharged home. Of surviving infants, 313 (93%) were examined by indirect ophthalmoscopy, as were eight infants who died before discharge. Sixty-nine infants (21.5% of 321) had acute retinopathy. On multiple logistic regression analysis, three variables made statistically significant independent contributions to the risk of any acute retinopathy; gestational age (P less than 0.0001), principal hospital caring for the infant (P less than 0.01) and treatment with indomethacin (P less than 0.01). Only two variables, gestational age (P less than 0.0001) and hospital (P less than 0.01), made significant contributions to the risk of stage 2 or more ROP. For both categories of ROP, timing of the examination also had a statistically significant effect (P less than 0.001). After adjustment for other significant predictor variables, it was estimated that approximately 70% of infants of less than 26 weeks' gestation were at risk of ROP and nearly 50% of stage 2 or more ROP, in comparison with less than 2% of infants of 32 weeks' gestation or more; infants treated with indomethacin were over 1.5 times more likely to have ROP than infants not so treated. Failure to enforce uniform timing of examination was the most serious defect in the study; only 205 (64%) of the 321 infants were examined at the recommended time. However, reanalysis of the model with information limited to these 205 infants yielded similar risk factors. The incidence of ROP, both observed (P less than 0.05) and adjusted for other significant variables in the regression model (P less than 0.01) was lowest in the two largest level III hospitals. These hospitals also had the best survival rates after adjustment for birthweight, gestation and gender (P less than 0.01). We speculate that the larger level III units obtained better results because their size and experience enabled them to provide a better overall quality of care.
本文报告了一项针对1986年在新西兰出生的所有极低出生体重(低于1500克)婴儿发生早产儿视网膜病变(ROP)危险因素的前瞻性研究。在入住新生儿病房的413例活产婴儿中,338例(81.2%)存活至出院回家。在存活婴儿中,313例(93%)接受了间接检眼镜检查,8例在出院前死亡的婴儿也接受了检查。69例婴儿(占321例的21.5%)患有急性视网膜病变。多因素logistic回归分析显示,有三个变量对任何急性视网膜病变的风险有统计学意义的独立贡献;胎龄(P<0.0001)、主要照顾婴儿的医院(P<0.01)和吲哚美辛治疗(P<0.01)。只有两个变量,即胎龄(P<0.0001)和医院(P<0.01),对2期或更严重ROP的风险有显著贡献。对于这两类ROP,检查时间也有统计学意义的影响(P<0.001)。在对其他显著预测变量进行调整后,估计孕周小于26周的婴儿中约70%有发生ROP的风险,2期或更严重ROP的风险接近50%,而孕周32周及以上的婴儿中这一比例不到2%;接受吲哚美辛治疗的婴儿发生ROP的可能性是未接受该治疗婴儿的1.5倍以上。未能严格执行统一的检查时间是该研究中最严重的缺陷;321例婴儿中只有205例(64%)在推荐时间接受了检查。然而,仅对这205例婴儿的信息重新分析模型,得出了类似的危险因素。在两家最大的三级医院中,观察到的ROP发病率(P<0.05)以及在回归模型中对其他显著变量进行调整后的发病率(P<0.01)最低。在对出生体重、孕周和性别进行调整后,这些医院的存活率也最高(P<0.01)。我们推测,规模较大的三级医院取得更好的结果是因为其规模和经验使其能够提供更好的整体护理质量。